The differential seroreactivity was assessed by the luminescence HaloTag-bead assays as well as by the electrochemical biosensing strategy, which confirmed by two different approaches the diagnostic ability of specific p53 and p63 proteoforms in CRC. The gene discussed is TP53; the disease is colorectal carcinoma.